Form 4: Clearwater Analytics CFO Sells Shares
Insider Transaction Report
Clearwater Analytics CFO James S. Cox reported the exercise of stock options and subsequent sale of Class A Common Stock, including shares withheld for tax obligations, under a Rule 10b5-1 plan.
Summary
- James S. Cox, Chief Financial Officer of Clearwater Analytics Holdings, Inc. (CWAN), reported transactions involving Class A Common Stock.
- On October 15, 2025, Mr. Cox exercised stock options to acquire 16,898 shares of Class A Common Stock at an exercise price of $4.4 per share.
- Following the option exercise, Mr. Cox's direct beneficial ownership increased to 360,881 shares.
- Concurrently, Mr. Cox sold 6,275 shares of Class A Common Stock at a price of $17.92 per share.
- An additional 10,623 shares were disposed of to cover tax withholding obligations related to the option exercise and settlement, also at $17.92 per share. This sale was mandated by the Issuer.
- A further 5,000 shares were sold at a weighted average price of $18.0459 per share, with individual trades ranging from $17.96 to $18.17.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Cox on March 11, 2024.
- After all reported transactions, Mr. Cox's direct beneficial ownership of Class A Common Stock stands at 338,983 shares.
- The stock options exercised had various vesting dates, including 297,000 shares on November 2, 2020, 180,000 shares on January 21, 2020, and 105,750 shares on January 5th of 2021, 2022, 2023, and 2024 respectively.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, these transactions are part of a pre-arranged 10b5-1 plan and include mandatory tax-related dispositions, indicating routine financial management rather than a change in company outlook. The executive also realized a significant profit from the option exercise.
Positives
- The exercise of stock options indicates that the CFO realized value from previously granted equity incentives.
- The sales were executed at prices significantly higher than the exercise price of $4.4, demonstrating a profitable transaction for the reporting person.
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to managing personal holdings rather than opportunistic selling based on new, undisclosed information.
Negatives
- The sale of shares by a Chief Financial Officer, even if pre-planned, can sometimes be perceived negatively by investors as it reduces insider ownership.
- A substantial portion of the disposed shares (10,623 shares) was used to cover tax withholding obligations, which represents a reduction in the executive's net beneficial ownership.
Risks
- While the sales were pre-planned, significant insider selling, even routine, can sometimes lead to negative market sentiment or speculation, potentially impacting the stock price.
- The market's interpretation of insider transactions can be unpredictable, and some investors may view any reduction in insider holdings as a lack of confidence, regardless of the underlying reason.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
- The sale to cover tax withholding obligations was mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.
Industry Context
Insider transactions, such as stock option exercises and subsequent share sales, are a routine part of executive compensation and personal financial planning in publicly traded companies. The use of a Rule 10b5-1 trading plan is a common practice to allow insiders to sell shares without concerns about trading on material non-public information, providing a structured and pre-determined approach to liquidity.
Stakeholder Impact
- Shareholders: May observe a reduction in direct insider ownership, though the pre-planned nature of the sales mitigates concerns about opportunistic selling.
- Employees: No direct impact mentioned, but general market perception of executive share sales could indirectly influence morale.
Key Dates
| Date | Description |
|---|---|
| 01/21/2020 | Vesting date for 180,000 shares of stock options. |
| 11/02/2020 | Vesting date for 297,000 shares of stock options. |
| 03/05/2021 | Vesting date for 105,750 shares of stock options. |
| 01/01/2022 | Vesting date for 105,750 shares of stock options. |
| 01/01/2023 | Vesting date for 105,750 shares of stock options. |
| 01/01/2024 | Vesting date for 105,750 shares of stock options. |
| 03/11/2024 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 10/15/2025 | Date of stock option exercise and subsequent sales of Class A Common Stock. |
| 05/20/2029 | Expiration date of the exercised stock options. |
Recommendation
holdThis Form 4 reports routine insider transactions, specifically the exercise of stock options and subsequent sales under a pre-arranged Rule 10b5-1 trading plan, along with mandatory tax-related dispositions. Such transactions are common for executives managing their personal finances and do not typically signal a fundamental change in the company's prospects or warrant a strong buy/sell recommendation. Investors should view this as a planned liquidity event for the CFO rather than an indicator of future company performance.
Keywords
Clearwater Analytics, CWAN, Insider Trading, Form 4, Stock Options, Share Sale, CFO, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.